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Introduction: The Portuguese Health Care System (PHCS), although considered efficient, can 
improve in hospital care provision (1). A new model of hospitalization, shifting care to the 
community, has emerged, named Domiciliary Hospitalization (DH) (2). This study aimed to 
determine the prevalence of Potentially Inappropriate Prescribing (PIP) in elders referred to DH. 
Materials and Methods: An exposure cohort was created, including patients hospitalized from 
August to September 2016 (n=33). Clinical and therapeutic information was obtained through 
the hospital database and information on actual drug use was acquired by overt observation at 
the patient’s home. Inclusion criteria were to have been transferred from conventional 
hospitalization to DH; being ≥ 65 years. Patients without ambulatory medication and those 
where the pharmaceutical visit occurred during the first day of DH were excluded. The PIP were 
analyzed using the GheOP3S Screening tool (3). Spearman’s rho was used to test the 
association between polypharmacy and PIP (SPSS v.24.0).   
Results: A sample of 17 patients met the inclusion criteria; with a mean age of 77.1 years {65-
94; SD=8.8}, 76.5% being male. Mean number of hospitalization days was 11.3±7.1, during 
which patients were prescribed approximately 9.9±3.9 drugs. A total of 167 drugs were 
analysed, 55 of which considered PIP (32.9%). Among these, 40% were inappropriate 
independent of the diagnosis (PIP-ID), 23.6% were inappropriate dependent on the diagnosis, 
25.5% were drug-drug interactions and 10.9% were potential prescribing omissions. The 
excessive use of benzodiazepines remains alarming, since among 21 PIP-ID, 47.6% were 
benzodiazepines, mostly intermediate acting (lorazepam and bromazepam). The use of 
antidepressants for longer periods than 1 year is also worrisome corresponding to 6 PIP-ID 
(28.6%). 57% of drug-drug interactions were between antidiabetic or insulin and beta-blockers 
(35.7% cardio selective). The number of PIP was strongly correlated with the number of 
prescribed drugs (r= 0.648, p = 0.005). 
Discussion and Conclusions: Medication review enabled the detection of various PIPs in 
patients discharged from the DH. The inclusion of a pharmacist in this unit was determinant to 
increase patient safety. The impact of this intervention is substantial on patients' health 
(reduction of adverse effects and increased adherence to therapy) but also on the economy of 
the PHCS (reduction in drug costs and hospital readmissions) (4). 
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